Individuals taking GLP-1 medications should follow the guidance of their prescribing healthcare provider
Kobayashi, A., Masumura, Y., and Yamazaki, N
Given the positive preclinical results and the growth of our aging populations, it is imperative to advance GH-RH antagonists into clinical trials to improve BPH outcomes
Understanding these limitations helps set realistic expectations and encourages more cautious decision-making, which ultimately reduces risk
Continue standard monitoring but recognize that the highest-risk period has passed
This synthetically manufactured peptide mimics growth hormone-releasing hormone (GHRH), stimulating the release of hGH, which effectively promotes muscle growth